Report of two cases with review of the literature;Maladie de castelman: A propos de deux cas et revue de la littérature

Journal Medical Libanais

Volumn 49, Issue 6, 2001, Pages 342-346

  Abboud, Bassam ^a   Jabbour, Elias ^a   Chahine, Georges ^a  

^a SAINT JOSEPH UNIVERSITY   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE;

ABDOMINAL PAIN; ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANOREXIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; EXCISION; HISTOPATHOLOGY; HUMAN; LAPAROTOMY; MALE; REMISSION; WEIGHT REDUCTION; PATHOLOGY; REVIEW;

ABDOMINAL PAIN; ADULT; ANOREXIA; GIANT LYMPH NODE HYPERPLASIA; HUMANS; MALE; WEIGHT LOSS;

EID: 0035526640     PISSN: 00239852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Clauvel JP. Maladie de Castelman. Revue de Presse d'Oncologie Clinique 2000; 9: 23-5.
2. Herrada J, Cabanillas F, Rice L, Manning J, Pugh W. The clinical behavior of localized and multicentric Castelman's disease. Ann Intern Med 1998; 128: 657-62.
3. Castelman B, Iverson L, Menendez VP. Localized mediastinal lymph node hyperplasia. Cancer 1956; 9: 822-30.
4. Frizzera G. Atypical lymphoproliferative disorders. In: Knowels DM, ed. Neoplastic Hematopathology. Baltimore, MD: Williams & Wilkins, 1992: 454-95.
5. Lino O, Frizzera G. Angiomyoid and follicular dendritic cell proliferative lesions in Castelman's disease of hyaline-vascular type: a study of 10 cases. Am J Surg Pathol 1997; 21: 1295-306.
6. D'Agay MF, Miclea JM, Clauvel JP et al. Castelman's disease: a well defined histological pattern for a widely divergent clinical spectrum. Nouv Rev Fr Hematol 1989; 31: 145-8.
7. Martin JM, Bell B, Ruether BA. Giant lymph node hyperplasia (Castelman's disease) of hyaline vascular type. Clinical heterogeneity with immunohistologic uniformity. Am J Clin Pathol 1985; 84: 439-46.
8. Peterson BA, Frizzera G. Multicentric Castelman's disease. Semin Oncol 1993; 20: 636-47.
9. Marti S, Pahissa A, Guardia J, Moragas A, Bacardi R. Multicentric giant lymph node hyperplasia. Favorable response to radiotherapy. Cancer 1983; 51: 808-10.
10. Keller AR, Hochholzer L, Castelman B. Hyaline-vascular and plasma cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972; 29: 670-83.
11. Frizzera G. Castelman's disease and related disorders. Semin Diagn Pathol 1988; 5: 346-64.
12. Frizzera G, Peterson BA, Bayrd ED, Goldman A. A systemic lymphoproliferative disorder with morphologic features of Castelman's disease. Clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 1985; 3: 1202-16.
13. Weisenburger DD, Nathwani BN, Winberg CD, Rappaport H. Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Hum Pathol 1985; 16: 162-72.
14. Kessler E. Multicentric giant lymph node hyperplasia. A report of seven cases. Cancer 1985; 56: 2446-51.
15. Keller AR, Hochholzer L, Castelman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972; 29: 670-83.
16. Gaba AR, Stein RS, Sweet DL, Variakojis D. Multicentric giant lymph node hyperplasia. Am J Clin Pathol 1978; 69: 86-90.
17. Frizzera G, Massarelli G, Banks PM, Rosai J. A systemic lymphoproliferative disorder with morphologic features of Castelman's disease. Am J Surg Pathol 1983; 7: 211-31.
18. Lachant NA, Sun NC, Leong LA, Oseas RS, Prince HE. Multicentric angiofollicular lymph node hyperplasia (Castelman's disease) followed by Kaposi's sarcoma in two homosexual males with the acquired immunodeficiency syndrome (AIDS). Am J Surg Pathol 1985; 83: 27-33.
19. Munoz G, Geijo P, Molden Hauer F, Perez-Moro E, Razquin J, Piris MA. Plasmacellular Castelman's disease and POEMS syndrome. Histopathology 1990; 17: 172-4.
20. Gili A, Ngan BY, Lester R. Castelman's disease associated with Pemphigus vulgaris. J Am Acad Dermatol 1991; 25: 955-9.
21. Ordi J, Grau JM, Junque A, Nomdedeu B, Palacin A, Cardesa A. Secondary (AA) amyloidosis associated with Castelman's disease. Report of two cases and review of the literature. Am J Clin Pathol 1993; 100: 394-7.
22. Oksenhendler E, Duarte M, Soulier J et al. Multicentric Castelman's disease in HIV infection: a clinical and pathological study of 20 patients. AIDS 1996; 10: 61-7.
23. Yoshizaki K, Matsuda T, Nishimoto N et al. Pathogenic significance of interleukine-6 (IL-6/BSF-2) in Castelman's disease. Blood 1989; 74: 1360-7.
24. Leger-Ravet MB, Peuchmaur M, Devergne O et al. Interleukin-6 gene expression in Castelman's disease. Blood 1991; 78: 2923-30.
25. Hsu SM, Waldron JA, Xie SS, Barlogie B. Expression of Interleukin-6 in Castelman's disease. Hum Pathol 1993; 24: 833-9.
26. Soulier J, Grollet E, Oksenhendler E et al. Kaposi's sarcoma associated herpesvirus-like DNA sequences in multicentric Castelman's disease. Blood 1995; 86: 1276-80.
27. Dupin N, Diss TM, Kellamp P et al. HHV-8 is associated with a plasmablastic variant of Castelman's disease that is linked to HHV-8 positive plasmablastic lymphoma. Blood 2000; 95: 1406-12.
28. Summerfield GP, Taylor W, Bellingham AJ, Goldsmith HJ. Hyaline-vascular variant of angiofollicular lymph node hyperplasia with systemic manifestations and response to corticosteroids. J Clin Pathol 1983; 36: 1005-11.
29. Feigert JM, Sweet DL, Coleman M et al. Multicentric angiofollicular lymph node hyperplasia with peripheral neuropathy, pseudotumor cerebri, IgA dysproteinemia, and thrombocytosis in women. A distinct syndrome. Ann Intern Med 1990; 113: 362-7.
30. Pavlidis NA, Skopouli FN, Bai MC, Bourantas CL. A successfully treated case of angiofollicular hyperplasia with oral chemotherapy (Castelman's disease). Med Pediatr Oncol 1990; 18: 333-5.
31. Chan TM, Cheng IK, Wong KL, Chan KW. Resolution of membranoproliferative glomerulonephritis complicating angiofollicular lymph node hyperplasia (Castelman's disease). Nephron 1993; 65: 628-32.
32. Reppeto L, Jaiprakash MP, Selby PJ, Gusterson BA, Williams HJ, McElwain TJ. Aggressive angiofollicular lymph node hyperplasia (Castelman's disease) treated with high dose melphalan and autologous bone marrow transplantation. Hematol Oncol 1986; 4: 213-17.
33. Pavlidis NA, Briassoulis E, Klouvas G, Bai M. Is Interferon-alpha an active agent in Castelman's disease? Ann Oncol 1992; 3: 85-6.
34. Beck JT, Hsu SM, Wijdenes J et al. Brief report: alleviation of systemic manifestations of Castelman's disaese by monoclonal anti-interleukine-6 antibody. N Engl J Med 1994; 330: 602-5.
35. Armitage JO, Castelman's disease. In: Greimer T, Armitage JO, Gross TG, editors. Atypical Lymphopro-liferative Diseases. American Society of Hematology. Hematology 2000, pp 136-7.